To further investigate the influence of BC on NCL binding of IMPAD1 mRNA, we overexpressed and knocked down BC in lung cancer cells and detected the levels of BC RNA in the NCL complex (Figure 4F‐a). The gene discussed is BPNT2; the disease is lung cancer.